In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Guest Post by Virginia Kaklamani, MD, DSc Co-director of the San Antonio Breast Cancer Symposium (SABCS)
No one ever wants to receive the startling diagnosis of cancer. It is one simple word that can incite...
The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently received funding from Genentech...
Guest Post by Angela Alexander, PhD Member of the AACR's Associate Member Council Communications Committee
Guest Post by Nazik Hammad, MD Vice President, North America, African Organization for Research and Training in Cancer (AORTIC)
The AACR and Philadelphia Media Network co-hosted an event in January entitled, “Cancer Precision Medicine: Big Ideas in Research,...
Thursday, Feb. 4 is World Cancer Day, an initiative by the Union for International Cancer Control (UICC) to raise...
Late last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for one of the most...
The AACR strongly aligns with all 69 National Cancer Institute (NCI)-designated centers, which jointly issued a call to action...
We asked experts in cancer precision medicine, immunotherapy, and prevention what breakthroughs we might expect to see in 2016...